Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Laurence Cristol-Dalstein"'
Autor:
Mylène Annonay, MD, Lisa Gauquelin, MD, Romain Geiss, MD, Mony Ung, MD, Laurence Cristol-Dalstein, MD, Marie-Ange Mouret-Reynier, MD PHD, Anthony Goncalves, MD PHD, Sophie Abadie-Lacourtoisie, MD, Eric Francois, MD, Christophe Perrin, MD, Johan Le Fel, MD, Véronique Lorgis, MD, Véronique Servent, MD, Lionel Uwer, MD, Christelle Jouannaud, MD, Marianne Leheurteur, MD, Florence Joly, MD PHD, Loic Campion, MD, Coralie Courtinard, MPH, Olivier Villacroux, MD, Thierry Petit, MD PHD, Pierre Soubeyran, MD, Catherine Terret, MD, Carine Bellera, PHD, Etienne Brain, MD PHD, Suzette Delaloge, MD MPH
Publikováno v:
Breast, Vol 60, Iss , Pp 138-146 (2021)
Background: Treatment and outcomes of patients with HER2-positive (HER2+) metastatic breast cancer (MBC) have dramatically improved over the past 20 years. This work evaluated treatment patterns and outcomes according to age. Methods: Women who initi
Externí odkaz:
https://doaj.org/article/ade3e6c3b78e4adab88c10f438f12991
Autor:
Zara Steinmeyer, Stéphane Gérard, Thomas Filleron, Stéphanie Lozano, Delphine Brechemier, Gabor Abellan Van Kan, Loic Mourey, Laurence Cristol-Dalstein, Laure De Decker, Yves Rolland, Laurent Balardy
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Half of cancer cases occur in patients aged 70 and above. Majority of older patients are eligible for chemotherapy but evidence for treating this population is sparse and severe toxicities affect more than half of them. Determinin
Externí odkaz:
https://doaj.org/article/ac9c27cc78b745ef9256fb5b9465e597
Autor:
Lionel Uwer, Mony Ung, Etienne Brain, C. Lefeuvre-Plesse, Veronique Lorgis, Johann Le Fel, Morgane Abiven, Pierre Soubeyran, Marianne Leheurteur, Carine Bellera, Sophie Abadie-Lacourtoisie, Thomas Bachelot, Loïc Campion, Marie-Ange Mouret-Reynier, Olivier Villacroux, Anthony Gonçalves, Suzette Delaloge, Laurence Cristol-Dalstein, Eric Francois, Christelle Jouannaud, Thierry Petit, C. Courtinard, V. Servent, Mylène Annonay
Publikováno v:
Cancer Research. 80:P1-19
Background: Prognosis of women with HER2+ metastatic breast cancer (MBC) has radically improved over the past 10 years, resulting from the implementation in clinical of anti-HER2 therapies. However, there are limited data regarding these trends in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b82ff64cf9e607504bed06184774e85
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-19
https://doi.org/10.1158/1538-7445.sabcs19-p1-19-19
Autor:
Carine Bellera, Christophe Perrin, Sophie Abadie-Lacourtoisie, Lisa Gauquelin, Marianne Leheurteur, Eric Francois, Catherine Terret, V. Servent, Romain Geiss, Veronique Lorgis, Christelle Jouannaud, Lionel Uwer, Suzette Delaloge, Anthony Gonçalves, Mony Ung, Etienne Brain, Thierry Petit, Olivier Villacroux, Florence Joly, Mylène Annonay, Coralie Courtinard, Pierre Soubeyran, Laurence Cristol-Dalstein, Johan Le Fel, Loïc Campion, Marie-Ange Mouret-Reynier
Publikováno v:
Breast
Breast, Elsevier, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩
Breast, Vol 60, Iss, Pp 138-146 (2021)
The Breast : Official Journal of the European Society of Mastology
Breast, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩
Breast, Elsevier, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩
Breast, Vol 60, Iss, Pp 138-146 (2021)
The Breast : Official Journal of the European Society of Mastology
Breast, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩
Background Treatment and outcomes of patients with HER2-positive (HER2+) metastatic breast cancer (MBC) have dramatically improved over the past 20 years. This work evaluated treatment patterns and outcomes according to age. Methods Women who initiat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3731ff80e1c38ffc118a60fc7423c5
https://hal.archives-ouvertes.fr/hal-03468488/file/BPH_TB_2021_Annonay.pdf
https://hal.archives-ouvertes.fr/hal-03468488/file/BPH_TB_2021_Annonay.pdf
Autor:
Gabor Abellan van Kan, Zara Steinmeyer, Laurence Cristol-Dalstein, D. Brechemier, Laurent Balardy, Laure de Decker, Stéphanie Lozano, Stéphane Gérard, Loic Mourey, Yves Rolland, Thomas Filleron
Publikováno v:
BMC Cancer
BMC Cancer, BioMed Central, 2019, 19 (1), pp.1153. ⟨10.1186/s12885-019-6377-7⟩
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Cancer, 2019, 19 (1), pp.1153. ⟨10.1186/s12885-019-6377-7⟩
BMC Cancer, BioMed Central, 2019, 19 (1), pp.1153. ⟨10.1186/s12885-019-6377-7⟩
BMC Cancer, Vol 19, Iss 1, Pp 1-8 (2019)
BMC Cancer, 2019, 19 (1), pp.1153. ⟨10.1186/s12885-019-6377-7⟩
Background Half of cancer cases occur in patients aged 70 and above. Majority of older patients are eligible for chemotherapy but evidence for treating this population is sparse and severe toxicities affect more than half of them. Determining prognos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946bea7acfd4b6d13e28cdc42a747ac6
https://www.hal.inserm.fr/inserm-02435253/document
https://www.hal.inserm.fr/inserm-02435253/document
Autor:
Roger Faroux, Thierry André, Eric Francois, Jean-François Seitz, Thomas Aparicio, Elena Paillaud, Laurence Cristol-Dalstein, Emilie Maillard, Laurent Bedenne, Elisabeth Carola, Frédérique Retornaz
Publikováno v:
Digestive and Liver Disease. 48:206-207
Gastroenterology and Digestive Oncology, CHU Avicenne, APHP, Bobigny, France Oncology, Centre Antoine Lacassagne, Nice, France Oncogeriatry, ICM Val d’Aurelle, Montpellier, France Oncology, CH Senlis, Senlis, France Federation Francophone de Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4465afac058d8176c89b4f94cbc0cece
https://doi.org/10.1016/j.dld.2015.11.023
https://doi.org/10.1016/j.dld.2015.11.023
Autor:
Roger Faroux, Eric Francois, L. Cany, Frédérique Retornaz, Laurence Cristol-Dalstein, Romain Desgrippes, Elena Paillaud, Jean C. Martin, Emilie Maillard, Elisabeth Carola, Sandrine Hiret, Laurent Mineur, Jean Francois Seitz, Olivier Bouché, Pierre-Luc Etienne, Thomas Aparicio, Gilles Breysacher
Publikováno v:
Journal of Clinical Oncology. 35:TPS3628-TPS3628
TPS3628 Background: Colon cancer (CC) occurs in around 50% of the patients after 70 years. Adjuvant chemotherapy (CT) has demonstrated a benefit on disease-free survival (DFS) and overall survival after a stage III CC resection. Nevertheless, adjuvan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c432b580cf641a41d2c258535a601ff3
https://doi.org/10.1200/jco.2017.35.15_suppl.tps3628
https://doi.org/10.1200/jco.2017.35.15_suppl.tps3628